Skip to content

AIPA trial

Implementation of an Artificial Intelligence Pain Assistant (AIPA) for postoperative pain management - AIPA trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57536
Enrollment
500
Registered
2025-05-14
Start date
2025-12-05
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain

Interventions

AI-pain assistant Archibald based on ChatGPT

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: To be eligible to participate in this study, a participant must meet all of the following criteria: Age = 18 years Postoperative patients scheduled for an admission on the Post Anesthesia Care Unit (PACU) Written informed consent from the patient

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from participating in this study:Currently being treated for severe chronic pain Patients who do not understand Dutch or English Substance abuse (drugs or alcohol) Patients with postoperative daycare admission (=24 hours) Patients after revision surgery within the same admission Refusal to participate Admission to critical care unit Patients with communication impairment and expressive limitations

Design outcomes

Primary

MeasureTime frame
NRSAre all dimensions of pain, including location, type of pain, and any aggravation with movement accurately asked

Secondary

MeasureTime frame
Did the digital pain assistant cover all questions from the digital pain assessment questionnaire in 30 minutes? Did the patient answer all questions within 30 minutes?Were there medically incorrect answers by the digital pain assistant? Quality of the conversation, rated on a 1 to 5 likert scale. Empathy of the assistant's responses, also on a 1 to 5 likert scale. Patient satisfaction (empathy, quality, completeness, recurrent use) 

Countries

Netherlands

Contacts

Public ContactJWH Korstanje

Erasmus MC, Universitair Medisch Centrum Rotterdam

j.korstanje@erasmusmc.nl0650033114

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)